Papers
19
Total Citations
321
H-Index
8
About
Dr. Francesco Barletta is a leading urologic surgeon and researcher whose work centers on advancing precision surgery for prostate and bladder cancers, with a particular focus on robot-assisted techniques and intraoperative imaging. His major contributions lie in pioneering the use of Prostate-Specific Membrane Antigen (PSMA) radioguided surgery (RGS) to detect lymph node metastases during robot-assisted radical prostatectomy, a field where his prospective phase II studies have been highly influential, amassing 94 citations for his 2022 interim analysis. He has also made significant strides in surgical safety, as evidenced by his 2020 study on radical cystectomy following neoadjuvant pembrolizumab (69 citations), and in quality improvement, with his 2018 work on implementing complication reporting guidelines (72 citations). Dr. Barletta’s research consistently demonstrates how novel imaging and standardized protocols can enhance oncologic outcomes while minimizing postoperative complications. His recent work on defining optimal target-to-background ratios for PSMA-RGS and exploring augmented reality in robotic surgery underscores his commitment to refining the next generation of image-guided interventions. Through his high-impact publications, Dr. Barletta has established himself as a key voice in the evolution of minimally invasive, precision-driven urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10